Dataset from A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With First Episode of Acute Optic Neuritis
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00007191
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of the study is to evaluate the efficacy of BIIB033 in subjects with
their first episode of unilateral acute optic neuritis (AON). The secondary objective of this
study is to assess the safety, tolerability, and pharmacokinetics (PK) of BIIB033 in this
study population.
创建时间：
2025-06-30
